Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 463

UNLV touts Food Genes and Me

Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.

Jan 17, 2019

Trice Medical traverses series C extension

The orthopaedic diagnostics equipment developer has added $18.5m to a series C round featuring Smith & Nephew that now stands at $37.6m.

Jan 17, 2019

Vast Therapeutics inhales $15m

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

Jan 17, 2019

Purdue Ag-celerator seeds $100,000

Plant sciences startups Heliponix and Karyosoft each secured $50,000 investments after winning the fifth cohort of Purdue’s Ag-celerator competition.

Jan 16, 2019

Cirius seeks entry to public markets

Novo-backed Cirius Therapeutics, which was supported at launch by Metabolic Solutions Development Company, will put the IPO proceeds into its lead liver disease treatment.

Jan 16, 2019

Von Tobel leaves NM to start Inspired Capital

NM Future Ventures alumni Alexa von Tobel and Mark Batsiyan have launched Inspired Capital, a venture capital firm aiming to raise $200m for its debut fund.

Jan 15, 2019

Winningtemp calls Chalmers for $3.7m round

Chalmers Ventures has invested more funding in human resources app developer Winningtemp, which is preparing its employee wellbeing software for international expansion.

Jan 15, 2019

NYU and Futurx spark Glixogen’s genesis

New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.

Jan 15, 2019

Mitsui helps Napajen nab series C funding

P&E Directions has joined existing investor Mitsui in a $12.4m round that increased the immunotherapy developer's total funding to more than $37m.

Jan 15, 2019

Investors deliver $2.5m to AmacaThera

Toronto’s AmacaThera is preparing clinical trials of a drug delivery hydrogel that could diminish the need for prescription opioid painkillers after surgery.

Jan 14, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here